• 2016. Diabetes Australia. Determining the cellular mechanisms of insulin resistance in obese women who develop gestational diabetes: Placenta-derived exosome, a possible biomarker for the early detection of gestational diabetes. 
  • 2017. Bill & Melissa Gates Foundation. Profiling of Placental Physiologic Signature During Pregnancy in Maternal Liquid Biopsies. 
  • 2016-2017. UQ-Ochsner Seed Fund. Placenta-derived exosomes, a possible biomarker for early detection of preeclampsia. 
  • 2016-2017. UQ-Ochsner Seed Fund for Collaborative Research, Ochsner Medical Center and University of Queensland. ‘MicroRNA and proteomic signatures of tumour-derived exosomes as early diagnostic tool of ovarian cancer progression’. 
  • 2015-2016. Exosomes as potential biomarkers for pancreatic cyst risk stratification for Pancreatic cancer. Funding source: 2015 Academic Title Holder Research Fund Scheme. 
  • 2015-2018. Tumor-derived exosomes and ovarian cancer. Funding source: generic donation. 
  • 2016-2019. NHMRC development grant (APP1114013). In vitro diagnostic for first trimester risk assignment of gestational diabetes. 
  • 2016 M+BS Emerging Leaders Medical Research Grant, titled Identification of exosomal miRNA targets involved in drug resistance in ovarian cancer. 
  • 2016 Brisbane Diamantina Health Partners (BDHP) Strategic Initiative Grant Scheme. The Queensland Gynaecological Cancer Initiative. 
  • 2016 UQ FirstLink Scheme. Large scale production and purification of placental exosomes with clinical Good Manufacturing Practice (GMP)-grade for biomarker applications. 

Projects available for students

  • Gestational diabetes
  • Preeclampsia
  • Preterm birth
  • In vitro fertilisation
  • Ovarian cancer
  • Colon cancer
  • Pancreatic cancer
  • Obesity and cancer
  • Obesity and complication of pregnancies